Biosensors

Biosensors: On 11 Sep, we highlighted that the counter has been slowly gaining momentum over regular share buy-backs done by company. Analysts have been highlighting the potential for share price upside, should Biosensors manage to net a value-accretive acquisition. Management recently noted that the group is making good progress on the merger and acquisition front, and is eyeing a number of potential targets that would help transform it into a global medical devices group.